CEN Biotech Total Liabilities

CEN Biotech (CENBF) currently reports a total liabilities of $11M as of September 2023. That compares with $10M in the prior-year period — up 5.9% year over year. Use the charts on this page to explore CEN Biotech's total liabilities history and peer comparisons.

CEN Biotech's total liabilities increased from $10M to $11M — a 5.9% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CEN Biotech reported $11M in total liabilities as of September 2023. That compares with $10M in the prior-year period — up 5.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CEN Biotech, and consider following CENBF for alerts when major investors trade the stock.